skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Improved positron emission tomography imaging of glioblastoma cancer using novel 68Ga-labeled peptides targeting the urokinase-type plasminogen activator receptor (uPAR)

Abstract

Not provided.

Authors:
; ; ; ; ; ;
Publication Date:
Research Org.:
Stanford Univ., CA (United States)
Sponsoring Org.:
USDOE Office of Science (SC)
OSTI Identifier:
1533306
DOE Contract Number:  
SC0008397
Resource Type:
Journal Article
Journal Name:
Amino Acids
Additional Journal Information:
Journal Volume: 49; Journal Issue: 6; Journal ID: ISSN 0939-4451
Publisher:
Springer
Country of Publication:
United States
Language:
English
Subject:
Biochemistry & Molecular Biology

Citation Formats

Loft, Mathias Dyrberg, Sun, Yao, Liu, Changhao, Christensen, Camilla, Huang, Daijuan, Kjaer, Andreas, and Cheng, Zhen. Improved positron emission tomography imaging of glioblastoma cancer using novel 68Ga-labeled peptides targeting the urokinase-type plasminogen activator receptor (uPAR). United States: N. p., 2017. Web. doi:10.1007/s00726-017-2407-4.
Loft, Mathias Dyrberg, Sun, Yao, Liu, Changhao, Christensen, Camilla, Huang, Daijuan, Kjaer, Andreas, & Cheng, Zhen. Improved positron emission tomography imaging of glioblastoma cancer using novel 68Ga-labeled peptides targeting the urokinase-type plasminogen activator receptor (uPAR). United States. doi:10.1007/s00726-017-2407-4.
Loft, Mathias Dyrberg, Sun, Yao, Liu, Changhao, Christensen, Camilla, Huang, Daijuan, Kjaer, Andreas, and Cheng, Zhen. Sat . "Improved positron emission tomography imaging of glioblastoma cancer using novel 68Ga-labeled peptides targeting the urokinase-type plasminogen activator receptor (uPAR)". United States. doi:10.1007/s00726-017-2407-4.
@article{osti_1533306,
title = {Improved positron emission tomography imaging of glioblastoma cancer using novel 68Ga-labeled peptides targeting the urokinase-type plasminogen activator receptor (uPAR)},
author = {Loft, Mathias Dyrberg and Sun, Yao and Liu, Changhao and Christensen, Camilla and Huang, Daijuan and Kjaer, Andreas and Cheng, Zhen},
abstractNote = {Not provided.},
doi = {10.1007/s00726-017-2407-4},
journal = {Amino Acids},
issn = {0939-4451},
number = 6,
volume = 49,
place = {United States},
year = {2017},
month = {3}
}

Works referenced in this record:

Mini-PEG spacering of VAP-1-targeting 68Ga-DOTAVAP-P1 peptide improves PET imaging of inflammation
journal, January 2011

  • Autio, Anu; Henttinen, Tiina; Sipilä, Henri J.
  • EJNMMI Research, Vol. 1, Issue 1
  • DOI: 10.1186/2191-219X-1-10

Animal models and therapeutic molecular targets of cancer: utility and limitations
journal, October 2014

  • Cekanova, Maria; Rathore, Kusum
  • Drug Design, Development and Therapy
  • DOI: 10.2147/DDDT.S49584

Evolving role of uPA/uPAR system in human cancers
journal, April 2008



journal, January 2004


Development and evaluation of peptidic ligands targeting tumour-associated urokinase plasminogen activator receptor (uPAR) for use in α-emitter therapy for disseminated ovarian cancer
journal, September 2007

  • Knör, Sebastian; Sato, Sumito; Huber, Timo
  • European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Issue 1
  • DOI: 10.1007/s00259-007-0582-3


journal, November 2011


Imaging of Urokinase-Type Plasminogen Activator Receptor Expression Using a 64Cu-Labeled Linear Peptide Antagonist by microPET
journal, August 2008


Structure-based Engineering of Species Selectivity in the Interaction between Urokinase and Its Receptor: IMPLICATION FOR PRECLINICAL CANCER THERAPY
journal, February 2010

  • Lin, Lin; Gårdsvoll, Henrik; Huai, Qing
  • Journal of Biological Chemistry, Vol. 285, Issue 14
  • DOI: 10.1074/jbc.M109.093492


journal, November 2011


68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers
journal, May 2012


Quantitative PET of Human Urokinase-Type Plasminogen Activator Receptor with 64Cu-DOTA-AE105: Implications for Visualizing Cancer Invasion
journal, January 2012


Improved PET Imaging of uPAR Expression Using new 64 Cu-labeled Cross-Bridged Peptide Ligands: Comparative in vitro and in vivo Studies
journal, January 2013

  • Persson, Morten; Hosseini, Masood; Madsen, Jacob
  • Theranostics, Vol. 3, Issue 9
  • DOI: 10.7150/thno.6810

First 18F-labeled ligand for PET imaging of uPAR: In vivo studies in human prostate cancer xenografts
journal, July 2013


First-in-human uPAR PET: Imaging of Cancer Aggressiveness
journal, January 2015

  • Persson, Morten; Skovgaard, Dorthe; Brandt-Larsen, Malene
  • Theranostics, Vol. 5, Issue 12
  • DOI: 10.7150/thno.12956

Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma
journal, October 2015

  • Persson, M.; Nedergaard, M. K.; Brandt-Larsen, M.
  • Journal of Nuclear Medicine, Vol. 57, Issue 2
  • DOI: 10.2967/jnumed.115.161703


journal, November 2010


Expression of Urokinase-Type Plasminogen Activator Receptor (uPAR) in Primary Central Nervous System Neoplasms
journal, January 2005


Strained Cyclooctyne as a Molecular Platform for Construction of Multimodal Imaging Probes
journal, March 2015

  • Sun, Yao; Ma, Xiaowei; Cheng, Kai
  • Angewandte Chemie International Edition, Vol. 54, Issue 20
  • DOI: 10.1002/anie.201500941

Synthesis and Characterization of a High-Affinity NOTA-Conjugated Bombesin Antagonist for GRPR-Targeted Tumor Imaging
journal, June 2013

  • Varasteh, Zohreh; Velikyan, Irina; Lindeberg, Gunnar
  • Bioconjugate Chemistry, Vol. 24, Issue 7
  • DOI: 10.1021/bc300659k

Imaging of human pancreatic cancer xenografts by single-photon emission computed tomography with 99mTc-Hynic-PEG-AE105
journal, July 2015